503 related articles for article (PubMed ID: 34858425)
1. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
Allam A; Yakou M; Pang L; Ernst M; Huynh J
Front Immunol; 2021; 12():767939. PubMed ID: 34858425
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
3. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.
Milosevic V; Östman A
Ups J Med Sci; 2024; 129():. PubMed ID: 38863724
[TBL] [Abstract][Full Text] [Related]
4. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
6. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
7. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
Piper M; Mueller AC; Karam SD
Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.
Wu F; Yang J; Liu J; Wang Y; Mu J; Zeng Q; Deng S; Zhou H
Signal Transduct Target Ther; 2021 Jun; 6(1):218. PubMed ID: 34108441
[TBL] [Abstract][Full Text] [Related]
9. Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives.
Fang Z; Meng Q; Xu J; Wang W; Zhang B; Liu J; Liang C; Hua J; Zhao Y; Yu X; Shi S
Cancer Commun (Lond); 2023 Jan; 43(1):3-41. PubMed ID: 36424360
[TBL] [Abstract][Full Text] [Related]
10. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
Front Immunol; 2021; 12():656364. PubMed ID: 34122412
[TBL] [Abstract][Full Text] [Related]
11. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
Front Immunol; 2021; 12():671595. PubMed ID: 34305902
[TBL] [Abstract][Full Text] [Related]
14. Roles and Regulation of Growth differentiation factor-15 in the Immune and tumor microenvironment.
Lodi RS; Yu B; Xia L; Liu F
Hum Immunol; 2021 Dec; 82(12):937-944. PubMed ID: 34412918
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
16. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
Li Z; Sun C; Qin Z
Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
[TBL] [Abstract][Full Text] [Related]
17. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
18. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
Xiao Y; Wang Z; Gu M; Wei P; Wang X; Li W
Clin Exp Med; 2024 Jun; 24(1):126. PubMed ID: 38864912
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway.
Li A; Chen P; Leng Y; Kang J
Oncogene; 2018 Nov; 37(45):5952-5966. PubMed ID: 29980788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]